top of page
Nelson Advisors > European HealthTech & MedTech Specialists


The Vagus Nerve Neuromodulation Ecosystem: Scientific Evidence, Market Dynamics and Investment Opportunities
The field of vagus nerve neuromodulation (VNN) is undergoing a profound transformation, moving beyond its established applications to emerge as a cornerstone of bioelectronic medicine. While vagus nerve stimulation (VNS) has long been a recognised treatment for refractory epilepsy and treatment-resistant depression, recent technological breakthroughs and landmark clinical trial results are expanding its therapeutic reach into a wide array of chronic inflammatory, neurological
Sep 16, 202518 min read


The European Private Equity Playbook for Value Creation in HealthTech & MedTech: Navigating the 2025 Landscape and Beyond
The European HealthTech and MedTech sectors are undergoing a profound transformation, moving from a fragmented, early-stage ecosystem to a mature, consolidating landscape ripe for sophisticated private equity (PE) strategies. This report serves as a strategic blueprint for PE firms aiming to capitalise on this evolution. The analysis reveals that the European digital health market has emerged as a global leader in funding growth, propelled by a strategic pivot towards fewer,
Sep 13, 202512 min read


European Healthcare Technology M&A: Valuation Multiples and Market Dynamics Report by Nelson Advisors
The European healthcare technology (HealthTech) mergers and acquisitions (M&A) market is navigating a period of cautious yet discernible rebound in 2025. This resurgence is primarily propelled by improving macroeconomic conditions, substantial private equity dry powder and a pervasive strategic imperative for digital transformation across the healthcare ecosystem.
Jun 28, 202518 min read
bottom of page